AcquisitionOther
Obsidian Therapeutics, Inc. acquired target
Public M&A record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Obsidian Therapeutics, Inc. -> target · $350 million
The combined company will also continue to support Galera’s pipeline.
Open source record (SEC) ↗